|
|||||
|
|
Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors |
|
| Authors: | Franck E. Nicolini H. Jean Khoury Luke Akard Delphine Rea Hagop Kantarjian Michele Baccarani Janis Leonoudakis Adam Craig Annie-Claude Benichou Jorge Cortes |
| Abstract: | |
| Keywords: | omacetaxine homoharringtonine advanced chronic myeloid leukemia tyrosine kinase inhibitors imatinib dasatinib nilotinib |